Paola Del Sindaco Selected Research

semaglutide

6/2022	Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.
3/2022	Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paola Del Sindaco Research Topics

Disease

4	Hypoglycemia (Reactive Hypoglycemia) 04/2024 - 12/2018
4	Type 2 Diabetes Mellitus (MODY) 04/2024 - 12/2018
3	Weight Gain 04/2024 - 12/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Ischemic Stroke 01/2005
1	Stroke (Strokes) 01/2005

Drug/Important Bio-Agent (IBA)

2	semaglutideIBA 06/2022 - 03/2022
2	Glucagon-Like Peptide ReceptorsIBA 06/2022 - 03/2022
2	InsulinsIBA 01/2020 - 12/2018
2	insulin degludecIBA 01/2020 - 12/2018
2	Insulin (Novolin)FDA Link 01/2020 - 12/2018
1	IDegLiraIBA 04/2024
1	Complement System Proteins (Complement)IBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2005
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2005
1	AntioxidantsIBA 01/2005
1	EnzymesIBA 01/2005
1	MicronutrientsIBA 01/2005

Therapy/Procedure

1	Therapeutics 04/2024
1	Glycemic Control 01/2020